马晓燕, 胡洪. 100例Ⅲ期卵巢上皮癌术后辅加化疗疗程次数与疗效的分析[J]. 中国肿瘤临床, 2004, 31(3): 141-143.
引用本文: 马晓燕, 胡洪. 100例Ⅲ期卵巢上皮癌术后辅加化疗疗程次数与疗效的分析[J]. 中国肿瘤临床, 2004, 31(3): 141-143.
Ma Xiao-yan, Hu Hong. Analysis of Adjuvant Chemotherapy in Patients with Stake一III Epithelial Ovarian Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(3): 141-143.
Citation: Ma Xiao-yan, Hu Hong. Analysis of Adjuvant Chemotherapy in Patients with Stake一III Epithelial Ovarian Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(3): 141-143.

100例Ⅲ期卵巢上皮癌术后辅加化疗疗程次数与疗效的分析

Analysis of Adjuvant Chemotherapy in Patients with Stake一III Epithelial Ovarian Cancer

  • 摘要: 目的:探索Ⅲ期上皮性卵巢癌术后辅助化疗疗程次数与预后的关系。方法:对天津市肿瘤医院1982年1月~1997年1月收治的Ⅲ期上皮性卵巢癌100例进行回顾性分析。结果:Ⅲ期上皮性卵巢癌术后辅助化疗≤6个疗程组与>6个疗程组比较,2年复发率、2年及5年生存率均无明显差异(P>0.05)。结论:Ⅲ期上皮性卵巢癌完成满意的减癌术后,化疗仍需达6个疗程,增加术后的辅助化疗的次数和时间并不一定能延长患者的肿瘤复发时间和生存期(P>0.05);透明细胞癌及卵巢腺鳞癌预后较差,应给予重视。

     

    Abstract: Objective : In order to study the relation between concreascence and ccurses oftreatment using adjuvant chemotherapy in Stage-Ⅲ epithelial ovarian cancer. Meth-ods : One hun-dred cases of Stage-Ⅲepithelial ovarian cancer were analyzed in Tianjin Cancer Hospital from1982 to 1997. Results : There were no differences (P>0.05) found in 2-,5 -year survival ratesand 2-year recurrence rate between the group A treated by adjuvant chemotherapy (≤ 6 ccursesof treatment) and group B(>6 ccurses of treatment), and can not prolong period of recurrencewith the increase of times and the extend of period of treat-ment (P>0.05). Conclusion : It stillneeds six ccurses of treatment to complete the operation of Stage-Ⅲ epithelial ovarian cancer.

     

/

返回文章
返回